Article
Prognostic models in myelodysplastic syndromes.
Hematology. American Society of Hematology. Education Program - 1 Jan 2013
Bejar Rafael
Abstract excerpt
Establishing the prognosis for patients with myelodysplastic syndromes (MDS) is a key element of their care. It helps patients understand the severity of their disease and set expectations for their future. For physicians, an accurate estimate of prognosis drives decisions about the timing and choice of therapeutic options to consider. The International Prognostic Scoring System (IPSS) has been the standard tool...
Topics
- Humans
- Models, Biological
- Mutation
- Myelodysplastic Syndromes
- Prognosis
- Risk Factors